Across TCGA pan-cancer cohorts, RNA5SP163 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNA5SP163’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where RNA5SP163 RNA is repressed in tumor relative to normal tissue. In most cancer types RNA5SP163 is over-expressed in tumor, although a few such as CHOL and KIRC show the opposite, repressed pattern.

CHOL and KIRC are the cancer types where RNA5SP163 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP163 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	Male	All	−1.771	<.001	2	view →
KIRC	Female	All	−0.098	.036	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNA5SP163 RNA expression & survival · all RNA5SP163 data types